Supplemental Figure to the research article "Differential changes in blood flow and oxygen utilization in active muscles between voluntary exercise and electrical muscle stimulatio... by Makoto Katagiri (17987598)

“…After EMS, rBFI and rMRO2 decreased more slowly than after VOL and remained significantly higher until the end of the recovery period. …”

Age-related trabecular bone loss in male TTD mice. by Claudia Nicolaije (172380)

“…(A) Trabecular bone volume fraction (BV/TV), (B) Endocortical volume (Ec.V.), (C) Trabecular number (Tb.N.), (D) Trabecular thickness (Tb.Th.). 100 cross-sections were measured in the metaphysis of TTD and wild type mice. …”

Molecular epidemiology of HIV-1 infection among men who have sex with men in Taiwan from 2013 to 2015 by Wei-You Li (3686827)

“…The annual prevalence and incidence of HIV-1 showed a downward trend from 2013 to 2015 (6.56%, 5.97 per 100 person-years in 2013; 4.53%, 3.97 per 100 person-years in 2014; 1.84%, 2.08 per 100 person-years in 2015). …”

syn-tasiRnas targeting the coat protein of potato virus Y confer antiviral resistance in <i>Nicotiana benthamiana</i> by Xingyue Zhao (1660597)

“…This indicated that syn-tasiR-CPpvy2 successfully targeted and silenced the PVY CP gene, effectively inhibiting viral infection. syn-tasiR-CPpvy1 displayed attenuated symptoms and decreased viral accumulation in these plants However, severe symptoms of PVY infection and a similar amount of viral accumulation as the control were observed in plants expressing syn-tasiR-CPpvy3. syn-tasiR-CPpvy/pvx, which targets both PVY and potato virus X (PVX), was engineered using a single precursor. …”

Table_4_Laparoscopic vs. Transabdominal Treatment for Overflow Fecal Incontinence Due to Residual Aganglionosis or Transition Zone Pathology in Hirschsprung's Disease Reoperation.X... by Feng Chen (25347)

“…Blood loss was significantly decreased in the LAR-PT group (75 ± 29.2 ml) compared to the TR-PT group (190 ± 51.4 ml) (P = 0.001). …”

Table_1_Laparoscopic vs. Transabdominal Treatment for Overflow Fecal Incontinence Due to Residual Aganglionosis or Transition Zone Pathology in Hirschsprung's Disease Reoperation.X... by Feng Chen (25347)

“…Blood loss was significantly decreased in the LAR-PT group (75 ± 29.2 ml) compared to the TR-PT group (190 ± 51.4 ml) (P = 0.001). …”

Serial changes in pulmonary function during follow-up after RAIT in patients with pulmonary metastases of differentiated thyroid cancer. by Eun Kyung Jang (732099)

“…The bold lines indicate the patients who demonstrated a significantly decreased pulmonary function (severe restrictive or obstructive pattern) during follow-up. …”

Presentation1_Cinnamomum zeylanicum Extract and its Bioactive Component Cinnamaldehyde Show Anti-Tumor Effects via Inhibition of Multiple Cellular Pathways.ppt by Sadhna Aggarwal (12718319)

“…The cancer cells showed a decreased expression of various PI3k-AKT-mTOR pathways related to VEGF, COX-2, Bcl-2, NF-κB, and proteins post-treatment.…”

Oriental Medicine Kyung-Ok-Ko Prevents and Alleviates Dehydroepiandrosterone-Induced Polycystic Ovarian Syndrome in Rats by Minhee Jang (521313)

“…However, the potential protective value of KOK for the treatment of polycystic ovarian syndrome (PCOS) is largely unknown. We investigated whether pre-administration (daily from 2 hours before PCOS induction) and post-administration (daily after induction of PCOS) of KOK (0.5, 1.0, and 2.0 g/kg/day, p.o.) could have a protective effect in a dehydroepiandrosterone (DHEA, s.c.)…”

Presentation1_Cinnamomum zeylanicum Extract and its Bioactive Component Cinnamaldehyde Show Anti-Tumor Effects via Inhibition of Multiple Cellular Pathways.ppt by Sadhna Aggarwal (12718319)

“…The cancer cells showed a decreased expression of various PI3k-AKT-mTOR pathways related to VEGF, COX-2, Bcl-2, NF-κB, and proteins post-treatment.…”

Table_3_Laparoscopic vs. Transabdominal Treatment for Overflow Fecal Incontinence Due to Residual Aganglionosis or Transition Zone Pathology in Hirschsprung's Disease Reoperation.X... by Feng Chen (25347)

“…Blood loss was significantly decreased in the LAR-PT group (75 ± 29.2 ml) compared to the TR-PT group (190 ± 51.4 ml) (P = 0.001). …”

Image1_Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function.JPEG by Lorenzo M. Fernandes (17038200)

“…It also increases AKT and ERK1/2 phosphorylation and decreases the expression of genes that regulate the maturation of lymphatic vessels. …”

Image3_Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function.JPEG by Lorenzo M. Fernandes (17038200)

“…It also increases AKT and ERK1/2 phosphorylation and decreases the expression of genes that regulate the maturation of lymphatic vessels. …”

Image4_Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function.JPEG by Lorenzo M. Fernandes (17038200)

“…It also increases AKT and ERK1/2 phosphorylation and decreases the expression of genes that regulate the maturation of lymphatic vessels. …”

Image4_Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function.JPEG by Lorenzo M. Fernandes (17038200)

“…It also increases AKT and ERK1/2 phosphorylation and decreases the expression of genes that regulate the maturation of lymphatic vessels. …”

Image1_Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function.JPEG by Lorenzo M. Fernandes (17038200)

“…It also increases AKT and ERK1/2 phosphorylation and decreases the expression of genes that regulate the maturation of lymphatic vessels. …”

Image3_Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function.JPEG by Lorenzo M. Fernandes (17038200)

“…It also increases AKT and ERK1/2 phosphorylation and decreases the expression of genes that regulate the maturation of lymphatic vessels. …”

EFFECTIVENESS OF CHIROPRACTIC ADJUSTMENT IN LUMBAR PAIN IN CROSSFIT PRACTITIONERS by DESIREE MOEHLECKE (12812300)

Identification of the potential inhibitors of malolactic fermentation in wines by Renata Vieira da MOTA (4651042)

Identification of the potential inhibitors of malolactic fermentation in wines by Renata Vieira da MOTA (4651042)